Skip to content
Oncology Research Hub

Research area

Lung Cancer clinical trials

Different types and stages of lung cancer are studied through research on investigational medications, radiation approaches, and screening methods. Whether you are reading for yourself or for someone in your family, Oncology Research Hub can help you find out if a study may be a fit.

Updated

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Lung cancer studies in numbers

lung cancer studies recruiting in the U.S.
885
states with a study site
51
studies that accept healthy volunteers
86

Source: ClinicalTrials.gov. Data processed .

Find lung cancer studies by state

These states have the most studies recruiting right now.

Lung cancer studies recruiting now

As of November 16, 2026, 885 lung cancer studies are recruiting participants in the United States, according to ClinicalTrials.gov. This is what they have in common.

What they test

  • medications542
  • other approaches159
  • biologics such as vaccines or antibodies119
  • procedures117
  • radiation64

A study can test more than one.

Main purpose

  • treating a condition591
  • supportive care44
  • screening26
  • diagnosis25

Phase

  • Early Phase 15
  • Phase 1174
  • Phase 1/2150
  • Phase 2179
  • Phase 2/312
  • Phase 377
  • Phase 46
  • No phase135
  • Observational147

Studies of devices and behavioral approaches have no phase.

Who runs them

  • university, hospital or other449
  • industry392
  • government44

Who they enroll

  • adults (18 to 64)879
  • older adults (65 and over)872
  • children (under 18)42

86 also accept healthy volunteers.

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 885 studies.

Recently updated lung cancer studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Texas Southwestern Medical Center
    Recruiting in
    Dallas, TX · Neptune City, NJ · Pittsburgh, PA · and 2 more U.S. locations
    Registry record
    NCT02468024 · updated
  2. Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Teligene US
    Recruiting in
    Athens, GA · Baltimore, MD · Fairfax, VA · and 3 more U.S. locations
    Registry record
    NCT05168566 · updated
  3. Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Aurora, CO
    Registry record
    NCT05179408 · updated
  4. LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    NovoCure GmbH
    Recruiting in
    Cary, NC · Dallas, TX · Edinburg, TX · and 10 more U.S. locations
    Registry record
    NCT06216301 · updated
  5. Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Atlanta, GA · Baltimore, MD · Charlotte, NC · and 28 more U.S. locations
    Registry record
    NCT06287775 · updated
  6. A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

    • Phase 1/2
    • Ages 18 to 75
    • All sexes
    Sponsor
    Tyligand Pharmaceuticals (Suzhou) Limited
    Recruiting in
    Fairfax, VA · Houston, TX · San Antonio, TX
    Registry record
    NCT06385925 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in the United States on ClinicalTrials.gov.

What lung cancer studies look at

Research in lung cancer covers investigational medications, radiation approaches, and screening methods, across different types and stages of the disease. The details vary. Because each study is built to answer one specific question, what the team would ask of you, or of the person you are caring for, changes from one study to the next.

Everything tested in a study is investigational. Researchers are still learning how well it works and what risks it carries. That is why the study is being run.

Who may be able to take part

Requirements are set study by study. Age, health history, current medications, and how lung cancer affects you can all be among them. People who do not have the condition are also enrolled in some studies.

Working out eligibility is not something you or a family member has to do. The study team checks it at a screening visit. Read how eligibility and screening work.

What taking part usually involves

  1. A first conversation

    First, a coordinator describes the study in general terms and answers your questions. Nothing else happens until that conversation has taken place.

  2. Informed consent

    Everything about the study is put on paper for you by the study team, with the known risks spelled out. Whether to agree is then your decision.

  3. Screening

    Screening uses health questions and tests to show whether the study is suitable for you. Some people who are screened do not go on to take part.

  4. Study visits

    Joining means attending scheduled visits, which let the team follow your health. Leaving the study is possible at any time.

Questions about lung cancer studies

Do I need a diagnosis to join a study about lung cancer?

That varies by study. A confirmed diagnosis is required for some, while in others you are assessed during screening. The study team will let you know which applies to you.

Would I have to change the care I receive now?

No change to your care should be made on your own. Whether current care can continue differs: some studies allow it and others do not. The study doctor goes through this with you, and before you decide you can discuss it with your own doctor.

Is there a cost to take part?

The study medication, study visits, and study tests generally come at no cost to participants. Find out more about costs.

Ask about lung cancer studies

A coordinator will contact you after you share a few details. Asking commits you to nothing, whether you are asking for yourself or for someone in your family.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Independent information

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call